ArticleACS omega2020
Active Metabolite of Aeruginascin (4-Hydroxy-
Article in ACS omega, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 31 citations in OpenAlex.
- Crystal structures of new psychoactive substances 4-HO-DET and 4-AcO-DET.Acta crystallographica. Section E, Crystallographic communications · 2026Article
- Syntheses and structures of two norpsilocin derivatives:Acta crystallographica. Section E, Crystallographic communications · 2026Article
- Serotonergic psychedelics induce distinct patterns of metabolic activity and covariance within biologically informed rat brain networks.Nature communications · 2026Article
- Chemical Composition and Biological Activities ofPharmaceuticals (Basel, Switzerland) · 2025Review
- Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases.Pharmacology & therapeutics · 2024Review
- Structural characterization and comparative analysis of polymorphic forms of psilocin (4-hy-droxy-Acta crystallographica. Section E, Crystallographic communications · 2024Article
- Synthesis and bioactivity of psilocybin analogues containing a stable carbon-phosphorus bond.RSC medicinal chemistry · 2024Article
- Bis(4-acetoxy-IUCrData · 2023Article
- Mechanisms and molecular targets surrounding the potential therapeutic effects of psychedelics.Molecular psychiatry · 2023Review
- Synthesis and structure of 4-hy-droxy-Acta crystallographica. Section E, Crystallographic communications · 2023Article
- A Review of Synthetic Access to Therapeutic Compounds Extracted fromPharmaceuticals (Basel, Switzerland) · 2022Review
- Psilocybin containing mushrooms: a rapidly developing biotechnology industry in the psychiatry, biomedical and nutraceutical fields.3 Biotech · 2022Review
- Structure-Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice.ACS pharmacology & translational science · 2022Article
- The methanol and ethanol solvates of 4-glutarato-Acta crystallographica. Section E, Crystallographic communications · 2022Article
- Genetic Survey of Psilocybe Natural Products.Chembiochem : a European journal of chemical biology · 2022Article
- Synthesis, Structural Characterization, and Pharmacological Activity of Novel Quaternary Salts of 4-Substituted Tryptamines.ACS omega · 2022Article
- The Therapeutic Potential of Psilocybin.Molecules (Basel, Switzerland) · 2021Review
- 2,5-Di-methyl-bufo-tenine and 2,5-di-methyl-bufo-teni-dine: novel derivatives of natural tryptamines found inActa crystallographica. Section E, Crystallographic communications · 2021Article
- Psilacetin derivatives: fumarate salts of the meth-yl-ethyl, meth-yl-allyl and diallyl variants of the psilocin prodrug.Acta crystallographica. Section E, Crystallographic communications · 2021Article
- Bufotenidinium iodide.IUCrData · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The putative active metabolite of aeruginascin, a naturally occurring tryptamine of "magic mushrooms," has been synthesized and structurally characterized. Competitive radioligand binding assays demonstrate that it has a high affinity at human serotonin receptors 5-HT
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.